NCT03441295

Brief Summary

Single-blind, multi-centre, prospective, randomized controlled trial comparing Ligamys Anterior Cruciate Ligament (ACL) repair, Internal Bracing ACL repair and conventional ACL reconstruction for relative clinical efficacy and economic benefit. Patients with a primary proximal acute ACL rupture will be included in either study 1 (0-4 weeks post rupture) or study 2 (5-12 weeks post rupture) of the LIBRE study.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
95

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2018

Completed
2 days until next milestone

Study Start

First participant enrolled

February 15, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 22, 2018

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2024

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2025

Completed
Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

5.9 years

First QC Date

February 13, 2018

Last Update Submit

May 14, 2024

Conditions

Keywords

ACL

Outcome Measures

Primary Outcomes (1)

  • International Knee Documentation Committee (IKDC) Score

    The International Knee Documentation Committee (IKDC) is a commonly used instrument to determine the outcome following various knee procedures, including ACL reconstructions. In essence, it is a subjective well-known tool that provides patients with an overall function score (range between 0 to 100). The score is interpreted as a measure of function with higher scores representing higher levels of function. The questionnaire addresses 3 categories: symptoms (i.e. pain, swelling, stiffness etc.), activity (rising from chair, going up and down stairs, jumping, squatting etc.) and knee function. The knee function studies focus primarily on one question: "How is the knee function post-operative compared to the situation before the injury?". In conclusion, the IKDC score is a reliable, well established and both patient and clinician friendly tool (i.e. it is easy and it requires little time to complete).

    Baseline (pre-rupture), week 13, week 26, week 52, week 104. At 6 months follow-up the primary outcome will be measured, a change of 13 IKDC points between the treatments is considered clinically meaningful.

Secondary Outcomes (9)

  • Failure (re-rupture/instability complaints)

    Day 1, week 2, week 6, week 13, week 26, week 52, week 104.

  • Tegner score

    Baseline (pre-rupture), week 13, week 26, week 52, week 104.

  • Lysholm score

    Baseline (pre-rupture), week 13 post-operative, week 26 post-operative, week 52 post-operative, week 104 post-operative

  • EQ-5D-5L

    Baseline (pre-operative), day 1, week 2, week 6, week 13, week 26, week 52, week 104.

  • Return to work/sport

    Day 1, week 2, week 6, week 13, week 26, week 52, week 104.

  • +4 more secondary outcomes

Study Arms (4)

Study 1 Ligamys

EXPERIMENTAL

Repair Surgery.

Procedure: Dynamic Intraligamentary Stabilization

Study 1 Internal Bracing

EXPERIMENTAL

Repair Surgery.

Procedure: Internal Brace Ligament Augmentation

Study 2 Internal Bracing

EXPERIMENTAL

Repair Surgery.

Procedure: Internal Brace Ligament Augmentation

Study 2 Reconstruction

ACTIVE COMPARATOR

Reconstructive Surgery.

Procedure: ACL Reconstruction

Interventions

DIS, Ligamys

Study 1 Ligamys

IBLA

Study 1 Internal BracingStudy 2 Internal Bracing

Conventional

Study 2 Reconstruction

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Primary acute proximal ACL rupture (MRI and per-operative confirmation): 3-digit ACL rupture classification, type A (supplement 1)
  • Between 18-50 years, male or female
  • Randomization and surgery within 4 weeks after the ACL rupture (Study 1)
  • Randomization and surgery between 5-12 weeks after the ACL rupture (Study 2)
  • The ACL remnant is suitable for repair in the three treatment groups: the distal ACL remnant must be in contact with the proximal remnant/femoral condyle for at least 75% (per-operative confirmation)
  • The patient is mentally and verbally capable of participating in the study.
  • Written informed consent (according to the International Conference on Harmonisation (ICH)-GCP Guidelines).

You may not qualify if:

  • Known posterior cruciate ligament (PCL) and/or posterolateral ligamentous complex (PLC), lateral collateral ligament (LCL) or medial collateral ligament (MCL) grade 3 injury.
  • Known osseous fractures that could impair revalidation and/or ACL repair
  • Patients with neurological disorders or systemic diseases
  • Patients with trauma/fractures in the lower limb in the past 6 months that could influence rehabilitation
  • Non-sportive patients with a Tegner score of \<3: these patients could probably counteract instability complaints with intensive physiotherapy.
  • Any inflammatory disease, Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), active malignancy
  • Patient not suited for intervention due to lack of mobility, meaning not achieving 90° of flexion before surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University Hospital, Antwerp

Edegem, Antwerp, 2650, Belgium

Location

University Hospital, Brussels

Jette, Brussels Capital, 1090, Belgium

Location

OLV Hospital

Aalst, Oost-Vlaanderen, 9300, Belgium

Location

Related Publications (1)

  • Heusdens CHW, Zazulia K, Roelant E, Dossche L, van Tiggelen D, Roeykens J, Smits E, Vanlauwe J, Van Dyck P. Study protocol: a single-blind, multi-center, randomized controlled trial comparing dynamic intraligamentary stabilization, internal brace ligament augmentation and reconstruction in individuals with an acute anterior cruciate ligament rupture: LIBRƎ study. BMC Musculoskelet Disord. 2019 Nov 18;20(1):547. doi: 10.1186/s12891-019-2926-0.

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Study Officials

  • Christiaan Heusdens

    UH, Antwerp

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Also the treating physiotherapist is blinded to the treatment the participant received.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Study 1 comparing Ligamys (DIS) and Internal Bracing (N=48). Study 2 comparing Internal Bracing and ACL Reconstruction (N=48).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

February 13, 2018

First Posted

February 22, 2018

Study Start

February 15, 2018

Primary Completion

January 15, 2024

Study Completion

August 30, 2025

Last Updated

May 16, 2024

Record last verified: 2024-05

Locations